Hardware, Equipment & Parts
Build Your Comparison
Side-by-side financial analysisStock Comparison
ALNT vs MFIN vs JPM vs BAC vs ENVA
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Credit Services
Banks - Diversified
Banks - Diversified
Financial - Credit Services
ALNT vs MFIN vs JPM vs BAC vs ENVA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Hardware, Equipment & Parts | Financial - Credit Services | Banks - Diversified | Banks - Diversified | Financial - Credit Services |
| Market Cap | $1.55B | $231M | $896.00B | $422.78B | $4.72B |
| Revenue (TTM) | $561M | $340M | $280.33B | $191.57B | $3.28B |
| Net Income (TTM) | $24M | $47M | $57.05B | $30.51B | $327M |
| Gross Margin | 31.2% | 59.3% | 60.0% | 56.1% | 37.6% |
| Operating Margin | 8.4% | 30.9% | 25.9% | 19.7% | 23.6% |
| Forward P/E | 36.2x | 8.8x | 14.4x | 12.6x | 11.5x |
| Total Debt | $197M | $316M | $942.38B | $365.90B | $4.56B |
| Cash & Equiv. | $41M | $202M | $343.34B | $231.84B | $72M |
ALNT vs MFIN vs JPM vs BAC vs ENVA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Allient Inc. (ALNT) | 100 | 258.8 | +158.8% |
| Medallion Financial… (MFIN) | 100 | 370.2 | +270.2% |
| JPMorgan Chase & Co. (JPM) | 100 | 341.0 | +241.0% |
| Bank of America Cor… (BAC) | 100 | 235.9 | +135.9% |
| Enova International… (ENVA) | 100 | 1273.2 | +1173.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ALNT vs MFIN vs JPM vs BAC vs ENVA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ALNT is the #2 pick in this set and the best alternative if momentum is your priority.
- +166.9% vs MFIN's +8.6%
MFIN carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and defensive.
- Lower volatility, beta 1.12, Low D/E 62.3%, current ratio 27.10x
- Beta 1.12, yield 4.6%, current ratio 27.10x
- NIM 7.3% vs BAC's 1.8%
- 21.1% NII/revenue growth vs BAC's -0.5%
JPM ranks third and is worth considering specifically for valuation efficiency.
- PEG 0.81 vs ALNT's 5.32
- 20.4% margin vs ALNT's 4.3%
BAC is the clearest fit if your priority is income & stability.
- Dividend streak 12 yrs, beta 0.86, yield 2.3%
- Beta 0.86 vs ALNT's 2.10
ENVA is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 18.6%, EPS growth 55.9%
- 24.2% 10Y total return vs JPM's 465.8%
- 5.2% ROA vs BAC's 0.9%, ROIC 10.4% vs 3.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 21.1% NII/revenue growth vs BAC's -0.5% | |
| Value | Lower P/E (8.8x vs 11.5x) | |
| Quality / Margins | 20.4% margin vs ALNT's 4.3% | |
| Stability / Safety | Beta 0.86 vs ALNT's 2.10 | |
| Dividends | 4.6% yield, 3-year raise streak, vs JPM's 1.9%, (1 stock pays no dividend) | |
| Momentum (1Y) | +166.9% vs MFIN's +8.6% | |
| Efficiency (ROA) | 5.2% ROA vs BAC's 0.9%, ROIC 10.4% vs 3.5% |
ALNT vs MFIN vs JPM vs BAC vs ENVA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
ALNT vs MFIN vs JPM vs BAC vs ENVA — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
JPM leads in 1 of 6 categories
MFIN leads 1 • ENVA leads 1 • ALNT leads 0 • BAC leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 2 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 825.0x MFIN's $340M. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to ALNT's 4.3%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $561M | $340M | $280.3B | $191.6B | $3.3B |
| EBITDAEarnings before interest/tax | $72M | $111M | $81.4B | $40.0B | $815M |
| Net IncomeAfter-tax profit | $24M | $47M | $57.0B | $30.5B | $327M |
| Free Cash FlowCash after capex | $41M | $126M | $100.9B | $12.6B | $1.9B |
| Gross MarginGross profit ÷ Revenue | +31.2% | +59.3% | +60.0% | +56.1% | +37.6% |
| Operating MarginEBIT ÷ Revenue | +8.4% | +30.9% | +25.9% | +19.7% | +23.6% |
| Net MarginNet income ÷ Revenue | +4.3% | +13.7% | +20.4% | +15.9% | +10.0% |
| FCF MarginFCF ÷ Revenue | +7.3% | +37.2% | +36.0% | +6.6% | +56.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +4.6% | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +52.4% | +16.3% | +16.0% | +18.3% | +28.6% |
Valuation Metrics
MFIN leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 5.5x trailing earnings, MFIN trades at a 92% valuation discount to ALNT's 69.2x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs ALNT's 10.18x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.6B | $231M | $896.0B | $422.8B | $4.7B |
| Enterprise ValueMkt cap + debt − cash | $1.7B | $346M | $1.50T | $556.8B | $9.2B |
| Trailing P/EPrice ÷ TTM EPS | 69.22x | 5.51x | 16.00x | 14.66x | 16.35x |
| Forward P/EPrice ÷ next-FY EPS est. | 36.19x | 8.80x | 14.40x | 12.56x | 11.51x |
| PEG RatioP/E ÷ EPS growth rate | 10.18x | — | 0.90x | 0.95x | — |
| EV / EBITDAEnterprise value multiple | 23.27x | 1.94x | 18.36x | 13.92x | 11.79x |
| Price / SalesMarket cap ÷ Revenue | 2.80x | 0.65x | 3.20x | 2.21x | 1.50x |
| Price / BookPrice ÷ Book value/share | 5.07x | 0.47x | 2.47x | 1.39x | 3.73x |
| Price / FCFMarket cap ÷ FCF | 31.26x | 1.83x | 8.88x | 33.52x | 2.67x |
Profitability & Efficiency
Evenly matched — MFIN and ENVA each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
ENVA delivers a 24.9% return on equity — every $100 of shareholder capital generates $25 in annual profit, vs $8 for ALNT. MFIN carries lower financial leverage with a 0.62x debt-to-equity ratio, signaling a more conservative balance sheet compared to ENVA's 3.41x. On the Piotroski fundamental quality scale (0–9), MFIN scores 7/9 vs JPM's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +8.0% | +9.4% | +15.9% | +10.1% | +24.9% |
| ROA (TTM)Return on assets | +4.1% | +1.6% | +1.3% | +0.9% | +5.2% |
| ROICReturn on invested capital | +7.7% | +17.2% | +4.5% | +3.5% | +10.4% |
| ROCEReturn on capital employed | +9.4% | +10.0% | +8.9% | +4.5% | +13.5% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 | 5 | 7 | 6 |
| Debt / EquityFinancial leverage | 0.65x | 0.62x | 2.60x | 1.21x | 3.41x |
| Net DebtTotal debt minus cash | $156M | $115M | $599.0B | $134.1B | $4.5B |
| Cash & Equiv.Liquid assets | $41M | $202M | $343.3B | $231.8B | $72M |
| Total DebtShort + long-term debt | $197M | $316M | $942.4B | $365.9B | $4.6B |
| Interest CoverageEBIT ÷ Interest expense | 2.31x | 1.07x | 0.74x | 0.48x | 79.01x |
Total Returns (Dividends Reinvested)
ENVA leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ENVA five years ago would be worth $54,017 today (with dividends reinvested), compared to $12,551 for MFIN. Over the past 12 months, ALNT leads with a +166.9% total return vs MFIN's +8.6%. The 3-year compound annual growth rate (CAGR) favors ENVA at 54.4% vs MFIN's 13.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +64.5% | -1.1% | -0.5% | +1.1% | +16.9% |
| 1-Year ReturnPast 12 months | +166.9% | +8.6% | +21.8% | +28.1% | +99.5% |
| 3-Year ReturnCumulative with dividends | +136.9% | +44.5% | +138.2% | +103.0% | +267.9% |
| 5-Year ReturnCumulative with dividends | +150.2% | +25.5% | +118.2% | +47.1% | +440.2% |
| 10-Year ReturnCumulative with dividends | +314.8% | +65.9% | +465.8% | +368.2% | +2421.0% |
| CAGR (3Y)Annualised 3-year return | +33.3% | +13.1% | +33.6% | +26.6% | +54.4% |
Risk & Volatility
Evenly matched — BAC and ENVA each lead in 1 of 2 comparable metrics.
Risk & Volatility
BAC is the less volatile stock with a 0.86 beta — it tends to amplify market swings less than ALNT's 2.10 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ENVA currently trades 97.8% from its 52-week high vs MFIN's 89.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.10x | 1.12x | 0.94x | 0.86x | 1.42x |
| 52-Week HighHighest price in past year | $95.65 | $11.00 | $337.25 | $57.55 | $193.54 |
| 52-Week LowLowest price in past year | $33.02 | $7.88 | $262.71 | $43.66 | $92.75 |
| % of 52W HighCurrent price vs 52-week peak | +95.5% | +89.2% | +95.1% | +97.3% | +97.8% |
| RSI (14)Momentum oscillator 0–100 | 70.7 | 57.4 | 59.1 | 68.3 | 72.9 |
| Avg Volume (50D)Average daily shares traded | 217K | 62K | 7.0M | 31.7M | 219K |
Analyst Outlook
Evenly matched — MFIN and JPM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ALNT as "Buy", MFIN as "Hold", JPM as "Buy", BAC as "Buy", ENVA as "Buy". Consensus price targets imply 9.1% upside for BAC (target: $61) vs -15.9% for ALNT (target: $77). For income investors, MFIN offers the higher dividend yield at 4.61% vs ALNT's 0.13%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $76.80 | $10.50 | $339.75 | $61.13 | $205.00 |
| # AnalystsCovering analysts | 5 | 9 | 61 | 54 | 10 |
| Dividend YieldAnnual dividend ÷ price | +0.1% | +4.6% | +1.9% | +2.3% | — |
| Dividend StreakConsecutive years of raises | 0 | 3 | 15 | 12 | 1 |
| Dividend / ShareAnnual DPS | $0.12 | $0.45 | $5.95 | $1.27 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.4% | +3.9% | +5.1% | +4.5% |
JPM leads in 1 of 6 categories (Income & Cash Flow). MFIN leads in 1 (Valuation Metrics). 3 tied.
ALNT vs MFIN vs JPM vs BAC vs ENVA: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ALNT or MFIN or JPM or BAC or ENVA a better buy right now?
For growth investors, Medallion Financial Corp.
(MFIN) is the stronger pick with 21. 1% revenue growth year-over-year, versus -0. 5% for Bank of America Corporation (BAC). Medallion Financial Corp. (MFIN) offers the better valuation at 5. 5x trailing P/E (8. 8x forward), making it the more compelling value choice. Analysts rate Allient Inc. (ALNT) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ALNT or MFIN or JPM or BAC or ENVA?
On trailing P/E, Medallion Financial Corp.
(MFIN) is the cheapest at 5. 5x versus Allient Inc. at 69. 2x. On forward P/E, Medallion Financial Corp. is actually cheaper at 8. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus Allient Inc. 's 5. 32x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — ALNT or MFIN or JPM or BAC or ENVA?
Over the past 5 years, Enova International, Inc.
(ENVA) delivered a total return of +440. 2%, compared to +25. 5% for Medallion Financial Corp. (MFIN). Over 10 years, the gap is even starker: ENVA returned +24. 2% versus MFIN's +65. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ALNT or MFIN or JPM or BAC or ENVA?
By beta (market sensitivity over 5 years), Bank of America Corporation (BAC) is the lower-risk stock at 0.
86β versus Allient Inc. 's 2. 10β — meaning ALNT is approximately 143% more volatile than BAC relative to the S&P 500. On balance sheet safety, Medallion Financial Corp. (MFIN) carries a lower debt/equity ratio of 62% versus 3% for Enova International, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ALNT or MFIN or JPM or BAC or ENVA?
By revenue growth (latest reported year), Medallion Financial Corp.
(MFIN) is pulling ahead at 21. 1% versus -0. 5% for Bank of America Corporation (BAC). On earnings-per-share growth, the picture is similar: Allient Inc. grew EPS 67. 1% year-over-year, compared to 1. 5% for JPMorgan Chase & Co.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ALNT or MFIN or JPM or BAC or ENVA?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus 4. 0% for Allient Inc. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MFIN leads at 50. 5% versus 8. 7% for ALNT. At the gross margin level — before operating expenses — MFIN leads at 96. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ALNT or MFIN or JPM or BAC or ENVA more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus Allient Inc. 's 5. 32x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Medallion Financial Corp. (MFIN) trades at 8. 8x forward P/E versus 36. 2x for Allient Inc. — 27. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BAC: 9. 1% to $61. 13.
08Which pays a better dividend — ALNT or MFIN or JPM or BAC or ENVA?
In this comparison, MFIN (4.
6% yield), BAC (2. 3% yield), JPM (1. 9% yield), ALNT (0. 1% yield) pay a dividend. ENVA does not pay a meaningful dividend and should not be held primarily for income.
09Is ALNT or MFIN or JPM or BAC or ENVA better for a retirement portfolio?
For long-horizon retirement investors, Bank of America Corporation (BAC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
86), 2. 3% yield, +368. 2% 10Y return). Allient Inc. (ALNT) carries a higher beta of 2. 10 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BAC: +368. 2%, ALNT: +314. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ALNT and MFIN and JPM and BAC and ENVA?
These companies operate in different sectors (ALNT (Technology) and MFIN (Financial Services) and JPM (Financial Services) and BAC (Financial Services) and ENVA (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ALNT is a small-cap quality compounder stock; MFIN is a small-cap high-growth stock; JPM is a large-cap deep-value stock; BAC is a large-cap deep-value stock; ENVA is a small-cap high-growth stock. MFIN, JPM, BAC pay a dividend while ALNT, ENVA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.